Profund Advisors LLC Deciphera Pharmaceuticals, Inc. Transaction History

Profund Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$13.58 - $17.36 $147,940 - $189,119	10,894 Added 46.7%	34,220 $538,000
Q4 2023 Feb 14, 2024	SELL	$10.11 - $16.54 $7,370 - $12,057	-729 Reduced 3.03%	23,326 $376,000
Q3 2023 Nov 13, 2023	SELL	$12.46 - $15.48 $224,653 - $279,104	-18,030 Reduced 42.84%	24,055 $305,000
Q2 2023 Aug 10, 2023	SELL	$13.28 - $15.96 $19,415 - $23,333	-1,462 Reduced 3.36%	42,085 $592,000
Q1 2023 May 11, 2023	BUY	$14.26 - $22.1 $620,980 - $962,388	43,547 New	43,547 $672,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Profund Advisors LLC with notifications on news.